1-222628106-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_198551.4(MIA3):c.886G>A(p.Val296Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000607 in 1,613,948 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0033 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00033 ( 0 hom. )
Consequence
MIA3
NM_198551.4 missense
NM_198551.4 missense
Scores
2
4
11
Clinical Significance
Conservation
PhyloP100: 4.78
Genes affected
MIA3 (HGNC:24008): (MIA SH3 domain ER export factor 3) Enables cargo receptor activity. Involved in several processes, including COPII-coated vesicle cargo loading; cell migration involved in sprouting angiogenesis; and regulation of leukocyte migration. Located in endoplasmic reticulum exit site and endoplasmic reticulum membrane. Is integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0073353946).
BP6
Variant 1-222628106-G-A is Benign according to our data. Variant chr1-222628106-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 2232903.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MIA3 | NM_198551.4 | c.886G>A | p.Val296Ile | missense_variant | 4/28 | ENST00000344922.10 | NP_940953.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MIA3 | ENST00000344922.10 | c.886G>A | p.Val296Ile | missense_variant | 4/28 | 5 | NM_198551.4 | ENSP00000340900.5 | ||
MIA3 | ENST00000470521.1 | n.898G>A | non_coding_transcript_exon_variant | 4/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.00324 AC: 493AN: 152128Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
493
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000813 AC: 202AN: 248356Hom.: 1 AF XY: 0.000638 AC XY: 86AN XY: 134868
GnomAD3 exomes
AF:
AC:
202
AN:
248356
Hom.:
AF XY:
AC XY:
86
AN XY:
134868
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000332 AC: 485AN: 1461700Hom.: 0 Cov.: 33 AF XY: 0.000303 AC XY: 220AN XY: 727130
GnomAD4 exome
AF:
AC:
485
AN:
1461700
Hom.:
Cov.:
33
AF XY:
AC XY:
220
AN XY:
727130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00325 AC: 495AN: 152248Hom.: 2 Cov.: 32 AF XY: 0.00304 AC XY: 226AN XY: 74444
GnomAD4 genome
AF:
AC:
495
AN:
152248
Hom.:
Cov.:
32
AF XY:
AC XY:
226
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
40
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
112
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Benign
T;T
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at